President Foundation de Beaumont Bonelli for Cancer Research, Italy
Dr. Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.
Dr. Evgeni V. Sokurenko
Department of Microbiology,Unversity of Washington,USA
Dr. Evgeni Sokurenko holds an M.D. and a Ph.D. in medical microbiology from the Moscow Medical Academy, Russian Federation. His postdoctoral research involved structure/functional analysis of the Escherichia coli fimbrial adhesins at the University of Tennessee, Memphis.Research in Sokurenko's laboratory is focused on understanding mechanisms of molecular adaptive evolution of genes in bacterial pathogens. There are three ongoing projects in the lab. The first project is directed towards understanding the mechanism of bacterial adhesion to host cells mediated by the most common kind of bacterial adhesins known - type 1, or mannose-sensitive, fimbriae. The second project is focused on identification of the 'selection footprints' of nucleotide polymorphisms that affect various types of genes encoding different adhesins of E. coli, Shigella and Salmonella strains. Finally, Sokurenko's laboratory is studying how on the genomic level adaptive mutations are accumulated in Pseudomonas aeruginosa and other bacteria during a single infection, e.g. in patients with cystic fibrosis or chronic urinary tract infection.
Dr. Joseph D.Rosenblatt
Chief of Hematology- Oncology,University of Miami,USA
Joseph D. Rosenblatt, M.D., is a Professor of Medicine, and the William J. Harrington Chair in Hematology and Chief of Hematology/Oncology in the Department of Medicine. He holds a graduate cross appointment in the Department of Microbiology and Immunology at UM. Dr. Rosenblatt is also a member of the Tumor Immunology Program. In the past 20 years, Dr. Rosenblatt has published over 100 journal articles and chapters in the areas of human retroviruses, immune therapies for cancer, and human gene therapy. Dr. Rosenblatt's work has general relevance to breast cancer and he has held major breast cancer grant funding in the past. Prior to his move to Miami, Dr. Rosenblatt served as Chief of the Hematology-Oncology Unit, and had a secondary appointment within the Department of Microbiology and Immunology at the University of Rochester from 1995-2001. Prior to 1995, Dr. Rosenblatt had been a member of the faculty in Hematology Oncology (Associate Professor) and was elected an Associate Member of the Molecular Biology Institute at UCLA, California. Dr Rosenblatt joined University of Miami in 2001, bringing extensive administrative and research experience
Dr.Ahmed G. Hegazi
president of the Egyptian Environmental Society National Research Center, Egypt
Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the department of Zoonotic Diseases, National Research Center, Egypt. Prof. Hegazi received his master's degree in 1979, and his PhD in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects.Hegazi Organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 166 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals.Dr. Hegazi is also the president of the Egyptian Environmental Society for Uses and Production of Bee Products, secretary of the Egyptian Society of Apitherapy, secretary general of the African Federation of Apiculture Associations, and a member of the International Apitherapy Commission (APIMONDIA).
Dr. G.P Talwar
Director of the National Institute of Immunology,India
Gursaran Prasad Talwar is a medical researcher working in the area of vaccines and immunocontraception In a 1994 paper his group demonstrated that women could be vaccinated to prevent pregnancy. Gursaran Prasad Talwar received BSc (Hons) and MSc (Tech) degrees from the University of Punjab, DSc from Sorbonne working at the Institut Pasteur, Paris and DSc (hc) from Bundhelkhand University (2004). He was Alexander von Humboldt Postdoctoral Fellow at Tübingen, Stuttgart and Munchen. He joined as Associate Professor of Biochemistry (1956) in the newly created All India Institute of Medical Sciences (AIIMS), New Delhi and also worked there as Professor and Head till 1983. He was Head, ICMR-WHO Research and Training Centre in Immunology for India and South East Asia (1972–91). He was the first Director of the National Institute of Immunology (NII) (1983–91) and also Professor of Eminence till 1994. He was Professor of Eminence and Senior Consultant, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi (1994–99) and Director Research, Talwar Research Foundation, New Delhi (2000- ). He was Visiting Professor, College de France (1991), Wellcome Professor at Johns Hopkins (1994–95), and Distinguished Professor at the Institute of Bioinformatics and Biotechnology,